Loratadine
Back to searchMolecule Structure
Scientific Name
Loratadine
Description of the Drug
Loratadine is a second generation antihistamine used to manage the symptoms of allergic rhinitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00455
http://www.drugbank.ca/drugs/DB00455
Brand Name(s)
Alavert, Children’s claritin, Claritin, Claritin hives relief, Claritin hives relief reditab, Claritin reditabs, Clarityn, Clarityne, Clarityn rapide, Hay-rite, Loratadine, Loratadine redidose, Roletra
Company Owner(s)
Perrigo Pharma International Designated Activity Co, Lannett Co Inc, Taro Pharmaceutical Industries Ltd, Marksans Pharma Ltd, Bayer Healthcare Llc, Sun Pharmaceutical Industries Ltd, Apotex Inc Etobicoke Site, Unique Pharmaceutical Laboratories, Pld Acquisitions Llc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4596 | |||
| PharmGKB | PA450266 | |||
| Human Metabolome Database | HMDB0005000 | |||
| WDI | LORATADIN | |||
| DrugBank | DB00455 | |||
| PubChem: Thomson Pharma | 14804759 | |||
| PubChem | 3957 | |||
| Mcule | MCULE-5073177964 | |||
| LINCS | LSM-5891 | |||
| Nikkaji | J23.749C | |||
| BindingDB | 22876 | |||
| EPA CompTox Dashboard | DTXSID2023224 | |||
| DrugCentral | 1605 | |||
| Brenda | 127070 | 23329 | 122950 | 125889 |
| ChemicalBook | CB54633221 | CB12630383 | CB5283770 | |
| Guide to Pharmacology | 7216 | |||
| GSRS | 236d3871-a486-479d-b589-cfba4507c20b | |||
| rxnorm | LORATADINE | ALAVERT | CLARITIN-D | CLARITIN |
| PubChem: Drugs of the Future | 12013131 | |||
| ChEBI | 6538 | |||
| NIH Clinical Collection | SAM001246987 | |||
| ZINC | ZINC000000537931 |
